Biotech Co. Wins $16.5M In Multiple Sclerosis Drug Fight
Acorda Therapeutics has been awarded $16.5 million by an arbitral panel following a dispute with Irish pharmaceutical company Alkermes over licensing royalties for the multiple sclerosis drug Ampyra, the New York-based...To view the full article, register now.
Already a subscriber? Click here to view full article